ImmBio: Anglo-Sino collaboration on vaccine against pneumococcal disease
UK vaccine R&D company ImmunoBiology (ImmBio) has recently signed a licensing agreement with LIBP (Lanzhou...
Read full article »
CEO
ImmBio is a Private company. ImmBio generates $1M in revenue per employee